Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$2.73 - $4.5 $39,767 - $65,551
-14,567 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$0.75 - $2.55 $6,105 - $20,759
-8,141 Reduced 35.85%
14,567 $23,000
Q4 2019

Feb 14, 2020

BUY
$1.65 - $2.48 $16,534 - $24,852
10,021 Added 78.99%
22,708 $56,000
Q3 2019

Nov 14, 2019

BUY
$1.48 - $2.52 $18,776 - $31,971
12,687 New
12,687 $21,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $373M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Zebra Capital Management LLC Portfolio

Follow Zebra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zebra Capital Management LLC with notifications on news.